Jimmy Lowery/LinkedIn
Mar 10, 2026, 12:47
Jimmy Lowery: The Clinical and Financial Responsibilities of Blood Bank Inventory
Jimmy Lowery, Principal Consultant at Lagniappe Laboratory Consulting LLC and Laboratory Quality Assurance Specialist at UNC Health Rex, shared a post on LinkedIn:
“Blood Bank inventory is both a clinical and financial responsibility.
Red cell and platelet wastage isn’t just a supply issue; it’s a leadership issue.
Every expired unit represents:
- Donor effort
- Processing cost
- Hospital acquisition expense
- Lost clinical utility
But aggressive minimization strategies can also create risk:
- Stockouts during emergencies
- Delayed availability for complex antibody patients
- Increased emergency release exposure
Effective transfusion service leadership requires balancing:
- Clinical safety
- Financial stewardship
- Data-driven forecasting
- Hospital-wide utilization patterns
Inventory management should be reviewed not just within the blood bank, but also at the executive level.
If asked today, could you quantify your expiration rate and explain your mitigation strategy?”
Stay updated with Hemostasis Today.
-
Apr 30, 2026, 15:56Benjamin Spurgeon: What’s next for Platelet Function Testing?
-
Apr 30, 2026, 15:38Ahvie Herskowitz: Is It Iron or ‘Oxidized Rust’? – A New Predictor of Aging.
-
Apr 30, 2026, 15:01Neil Morgan: New Collaborative Research Review on Large‐Scale Genetic Analysis in the Bleeding Disorders Community
-
Apr 30, 2026, 14:52Neema Ngugi: Understanding the D-Dimer Test – A Key Tool in Detecting Blood Clots
-
Apr 30, 2026, 14:45Steven Brown: Contributing to AMSSM CRN Orthobiologics Research on PRP in Muscle Injury and Tendinopathy
-
Apr 30, 2026, 14:33Abdul Mannan: The Clinical Pattern That Should Make You Think of VEXAS
-
Apr 30, 2026, 14:28Jennifer Le Mac: How the Immune System Shapes Venous Thrombosis
-
Apr 30, 2026, 14:22Samantha Xavier: Successfully Defended My PhD Thesis on P-Selectin as a Biomarker for Venous Thromboembolism
-
Apr 30, 2026, 14:09Robert Lufkin: Anti-Amyloid Drugs Fail Alzheimer’s Patients